226 related articles for article (PubMed ID: 1651858)
1. Analgesia mediated by spinal kappa-opioid receptors.
Goodchild CS; Sanghera S; Serrao JM; Gent JP
Eur J Anaesthesiol; 1991 May; 8(3):227-31. PubMed ID: 1651858
[TBL] [Abstract][Full Text] [Related]
2. Spinally mediated antinociception following intrathecal chlordiazepoxide--further evidence for a benzodiazepine spinal analgesic effect.
Boulter N; Serrao JM; Gent JP; Goodchild CS
Eur J Anaesthesiol; 1991 Sep; 8(5):407-11. PubMed ID: 1657599
[TBL] [Abstract][Full Text] [Related]
3. Reversal by naloxone of spinal antinociceptive effects of fentanyl, ketocyclazocine and midazolam.
Serrao JM; Goodchild CS; Gent JP
Eur J Anaesthesiol; 1991 Sep; 8(5):401-6. PubMed ID: 1657598
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
Tiseo PJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
[TBL] [Abstract][Full Text] [Related]
5. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists.
Aanonsen LM; Wilcox GL
J Pharmacol Exp Ther; 1987 Oct; 243(1):9-19. PubMed ID: 2822907
[TBL] [Abstract][Full Text] [Related]
6. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
7. gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
Nadeson R; Guo Z; Porter V; Gent JP; Goodchild CS
J Pharmacol Exp Ther; 1996 Aug; 278(2):620-6. PubMed ID: 8768712
[TBL] [Abstract][Full Text] [Related]
8. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
Chen SR; Pan HL
Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive actions of intrathecal xylazine: interactions with spinal cord opioid pathways.
Goodchild CS; Guo Z; Davies A; Gent JP
Br J Anaesth; 1996 Apr; 76(4):544-51. PubMed ID: 8652328
[TBL] [Abstract][Full Text] [Related]
10. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1991 Nov; 259(2):582-9. PubMed ID: 1658305
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
Caram-Salas NL; Reyes-García G; Bartoszyk GD; Araiza-Saldaña CI; Ambriz-Tututi M; Rocha-González HI; Arreola-Espino R; Cruz SL; Granados-Soto V
Eur J Pharmacol; 2007 Nov; 573(1-3):75-83. PubMed ID: 17643411
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
Rady JJ; Elmer GI; Fujimoto JM
J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
[TBL] [Abstract][Full Text] [Related]
13. Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception.
Wang Y; Zhang Y; Wang W; Cao Y; Han JS
Exp Neurol; 2005 Mar; 192(1):156-62. PubMed ID: 15698629
[TBL] [Abstract][Full Text] [Related]
14. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
Schmauss C; Yaksh TL
J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
Steinfels GF; Cook L
J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
[TBL] [Abstract][Full Text] [Related]
17. [Cholecystokinin octapeptide (CCK-8) antagonized analgesia mediated by mu and kappa opioid receptors].
Wang XH; Wang XJ; Han JS
Sheng Li Xue Bao; 1990 Jun; 42(3):219-25. PubMed ID: 1982023
[TBL] [Abstract][Full Text] [Related]
18. Correlation between magnitude and opioid mediation of stress-induced analgesia: individual differences and the effect of selective breeding.
Panocka I; Sadowski B
Acta Neurobiol Exp (Wars); 1990; 50(6):535-8. PubMed ID: 2131737
[TBL] [Abstract][Full Text] [Related]
19. Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat.
Zorman G; Belcher G; Adams JE; Fields HL
Brain Res; 1982 Mar; 236(1):77-84. PubMed ID: 6279238
[TBL] [Abstract][Full Text] [Related]
20. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
Castillo R; Kissin I; Bradley EL
Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
